AtriCure (ATRC) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
18 May, 2026Opening remarks and agenda
Meeting conducted virtually to enable broad stockholder participation.
Agenda and rules of conduct were made available on the meeting website.
Stockholders could submit questions via the web portal, with follow-up promised for unanswered queries.
Board and executive committee updates
Introduction of all current board members present at the meeting.
Shareholder proposals
Election of nine directors for a one-year term.
Ratification of Deloitte as the independent registered public accounting firm for 2026.
Amendment to the 2023 Stock Incentive Plan to increase authorized shares by 1,500,000.
Amendment to the 2018 Employee Stock Purchase Plan to increase authorized shares by 750,000.
Advisory vote on executive compensation (say on pay) as required by Dodd-Frank.
Latest events from AtriCure
- 2026 growth driven by innovation, exclusive clinical data, and expanding market opportunities.ATRC
Bank of America Global Healthcare Conference 202612 May 2026 - Q1 2026 revenue rose 14.3% to $141.2M, with profitability and strong 2026 outlook.ATRC
Q1 20268 May 2026 - Board recommends all proposals, highlights diversity, risk oversight, and pay-for-performance.ATRC
Proxy filing6 Apr 2026 - Annual meeting to vote on directors, auditor, stock plans, and executive pay.ATRC
Proxy filing6 Apr 2026 - 2026 growth driven by pain management and open heart innovations, with strong clinical trial momentum.ATRC
The Citizens Life Sciences Conference 202610 Mar 2026 - Double-digit revenue growth and margin gains in 2025 set up higher profitability for 2026.ATRC
Q4 202518 Feb 2026 - Q2 revenue up 15.2% to $116.3M; 2024 guidance projects strong growth despite higher expenses.ATRC
Q2 20242 Feb 2026 - Consistent growth, strong innovation, and global expansion position the business for long-term success.ATRC
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Q3 2024 revenue up 17.9% year-over-year, with strong global growth and raised guidance.ATRC
Q3 202418 Jan 2026